Atlas Trials

Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout

Clinical trial NCT02500641 · COMPLETED

Trial details

NCT number
NCT02500641
Sponsor
Menarini International Operations Luxembourg SA
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Gout
Start date
2015-08-17
Primary completion
2017-05-10
Enrollment
196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.